tiprankstipranks
Arcadia Biosciences (RKDA)
NASDAQ:RKDA
US Market

Arcadia Biosciences (RKDA) Financial Statements

478 Followers

Arcadia Biosciences Financial Overview

Arcadia Biosciences's market cap is currently $2.78M. The company's EPS TTM is $-0.97; its P/E ratio is -1.16; Arcadia Biosciences is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 4.86M$ 5.04M$ 4.45M$ 7.42M$ 6.78M
Gross Profit$ 1.76M$ 2.08M$ 2.28M$ 1.32M$ -1.93M
Operating Income$ -9.99M$ -3.65M$ -6.10M$ -14.01M$ -35.53M
EBITDA$ -9.84M$ -7.50M$ -5.73M$ -14.75M$ -27.71M
Net Income$ -2.34M$ -7.04M$ -13.98M$ -15.38M$ -14.66M
Balance Sheet
Cash & Short-Term Investments$ 4.56M$ 4.24M$ 11.64M$ 20.64M$ 28.68M
Total Assets$ 6.55M$ 13.52M$ 19.70M$ 28.92M$ 43.92M
Total Debt$ 0.00$ 155.00K$ 1.01M$ 2.02M$ 3.29M
Net Debt$ -259.00K$ -4.09M$ -5.51M$ -18.63M$ -25.39M
Total Liabilities$ 2.41M$ 7.29M$ 7.00M$ 8.02M$ 12.72M
Stockholders' Equity$ 4.14M$ 6.22M$ 12.84M$ 21.03M$ 31.09M
Cash Flow
Free Cash Flow$ -4.74M$ -9.64M$ -15.30M$ -14.05M$ -26.88M
Operating Cash Flow$ -4.74M$ -9.63M$ -15.29M$ -13.98M$ -25.87M
Investing Cash Flow$ 750.00K$ 7.34M$ -4.34M$ 1.42M$ 16.61M
Financing Cash Flow$ 6.00K$ 9.00K$ 5.51M$ 4.52M$ 21.90M
Currency in USD

Arcadia Biosciences Earnings and Revenue History

Arcadia Biosciences Debt to Assets

Arcadia Biosciences Cash Flow

Arcadia Biosciences Forecast EPS vs Actual EPS